Compare drug alternatives
Ajovy® Alternatives
Ajovy®
(Fremanezumab)
Ajovy
-
Migraine
- Emgality®
- Vyepti®
- Aimovig®
- Nurtec ODT®
- Ubrelvy®
Prescription Only
Ajovy is a prescription medication that can be self-injected once a month or once every three months under the skin to prevent migraine headaches. The most commonly reported side effect is injection site reactions. Ajovy does not seem to cause constipation. Additionally, there are no known drug interactions.
Ajovy is FDA approved for the following indications: Migraine prevention.
Qulipta®
(Atogepant)
Qulipta
-
Migraine
- Emgality®
- Vyepti®
- Aimovig®
- Nurtec ODT®
- Ubrelvy®
Prescription Only
Qulipta is a prescription medication that is used as a preventative treatment for episodic migraines. It is a tablet that is taken once daily. The most common side effects are fatigue, nausea, and constipation.
Qulipta is FDA approved for the following indications: Migraine prevention.
Dosage & Administration
Administration
Subcutaneous
Oral
Dosing
225 mg monthly or 675 mg every 3 months (as three consecutive injections of 225 mg each)
10 mg, 30 mg, or 60 mg once daily. Severe Renal Impairment or End-Stage Renal Disease: 10 mg once daily.
Latin Shorthand
225 mg/mo or 675 mg q3mo
10mg qd, 30mg qd or 60mg qd
Renal Impairment: 10mg qd
Financial Assistance
Copay
$5
$0
Annual Cap
Patient specific maximum benefit.
$6,000
Assistance Expiration
12/31/2023
12 30-day prescription fills
Generics
No lower-cost generic available
No lower-cost generic available